Haowei He
Overview
Explore the profile of Haowei He including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
294
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cui Y, Zhou X, Zhang J, Fang B, Ge J, Tang H, et al.
Cell Commun Signal
. 2024 Nov;
22(1):560.
PMID: 39574183
Background: In cases of advanced seminoma, up to 30% of patients may manifest cisplatin resistance, necessitating aggressive salvage therapy, with a consequent 50% risk of mortality attributable to cancer. Nevertheless,...
2.
Du B, Zhou Y, Li W, He H, Chen M, Feng N
Mol Biomed
. 2024 Nov;
5(1):56.
PMID: 39528875
No abstract available.
3.
He X, He H, Hou Z, Wang Z, Shi Q, Zhou T, et al.
EMBO J
. 2024 Sep;
43(21):5057-5084.
PMID: 39284914
ER-phagy, a selective form of autophagic degradation of endoplasmic reticulum (ER) fragments, plays an essential role in governing ER homeostasis. Dysregulation of ER-phagy is associated with the unfolded protein response...
4.
Fu D, Shi X, Yi X, Wu D, He H, Zhou W, et al.
BMC Urol
. 2024 Jul;
24(1):147.
PMID: 39014364
Background: Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) has been confirmed to play oncogenic role in many cancers. However, the role and mechanism of IGF2BP2 in bladder cancer (BCa)...
5.
Miao H, Zhou Y, Ge S, Gu Y, Qu L, Zhou W, et al.
Mol Genet Genomic Med
. 2024 Jul;
12(7):e2488.
PMID: 38963008
Background: This study aimed to identify disease-causing variants within a Chinese family affected by Birt-Hogg-Dubé syndrome (BHDS), which arises from an autosomal dominant inheritance pattern attributed to variants in the...
6.
Wu D, Zhou Y, Shi X, Yi X, Sheng Z, Fan L, et al.
Toxicol Appl Pharmacol
. 2024 May;
487:116975.
PMID: 38762191
Kidney renal clear cell carcinoma (KIRC) is a highly immune-infiltrated kidney cancer with the highest mortality rate and the greatest potential for invasion and metastasis. Solute carrier family 11 member1...
7.
Zhou Y, Gu Y, Tang C, Dong J, Xu S, Sheng Z, et al.
Front Oncol
. 2023 Nov;
13:1239405.
PMID: 37941564
Introduction: Metastatic renal cell carcinoma (mRCC) with sarcomatoid features has a poor prognosis. Cytoreductive radical nephrectomy (CRN) can improve prognosis, but patient selection is unclear. This study aimed to develop...
8.
Zhang J, Wang Y, Jiang B, He H, Huang S, Wang C, et al.
Nat Commun
. 2023 Sep;
14(1):5940.
PMID: 37741826
Accurate evaluation of Li-ion battery (LiB) safety conditions can reduce unexpected cell failures, facilitate battery deployment, and promote low-carbon economies. Despite the recent progress in artificial intelligence, anomaly detection methods...
9.
Qu L, Chen H, Chen Q, Ge S, Jiang A, Yu N, et al.
MedComm (2020)
. 2023 Jul;
4(4):e300.
PMID: 37484972
There is significant variability with respect to the prognosis of nonmetastatic clear cell renal cell carcinoma (ccRCC) patients with venous tumor thrombus (VTT). By applying multiregion whole-exome sequencing on normal-tumor-thrombus-metastasis...
10.
Hong Z, Chen X, Wang L, Zhou X, He H, Zou G, et al.
Hum Cell
. 2023 Jul;
36(5):1790-1803.
PMID: 37418232
Renal cell carcinoma (RCC) is the most common form of kidney cancer in adults. Despite new therapeutic modalities, the outcomes for RCC patients remain unsatisfactory. Rho-associated coiled-coil forming protein kinase...